Leibniz Institute DSMZ
DSMZ Digital Diversity
Login
Classic view
All enzymes
Enzyme history
BRENDA support
Any feedback?
Please rate this page
(search_result.php)
😁
😐
😡
(
0
/150)
Send feedback
BRENDA support
Refine search
Search Application
Application:
show
10
50
100
results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Recommended Name:
EC Number:
contains
exact
begins with
ends with
use * as joker
Commentary:
contains
exact
begins with
ends with
use * as joker
Organism
:
contains
exact
begins with
ends with
use * as joker
Reference:
contains
exact
begins with
ends with
use * as joker
Search term:
Results
1
-
2
of
2
download as CSV
download all results as CSV
EC Number
Application
Commentary
Reference
1.14.14.80
medicine
hepatic CYP4A14 expression is up-regulated in three murine models of nonalcoholic fatty liver disease. Overexpression of CYP4A14 in the livers of C57BL/6 mice results in a fatty liver phenotype with a significant increase in hepatic fatty acid translocase (FAT/CD36) expression. CYP4A14 gene-deficient mice fed a high-fat diet or a methionine and choline-deficient diet exhibit attenuated liver lipid accumulation and reduced hepatic FAT/CD36 expression. Hepatic inflammation and fibrosis is markedly ameliorated in methionine and choline-deficient diet-fed CYP4A14-deficient mice
746320
1.14.14.80
medicine
specific inhibition of either the CYP2C epoxygenase or the CYP4A omega-hydroxylase abrogates peroxisomal proliferation induced by the hypolipidemic drug cirpofibrate
734431
Results
1
-
2
of
2
download as CSV
download all results as CSV